#StudyGraphics: Gastric bypass surgery may reduce the risk of esophagogastric cancer in patients with obesity
Click to read this study in JAMA Surgery.
Tag: gastric cancer
FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option
1. Overall survival rate at 12 months for the FOLFOX arm and ipilimumab arm was 70% and 57%, respectively. 2. ...
#VisualAbstract: Nivolumab plus chemotherapy improves progression-free survival in gastric or gastroesophageal junction cancer
Click to read this study in The Lancet Oncology.
Adjuvant chemotherapy associated with an improved overall survival for patients with locally advanced gastric cancer
1. In this retrospective cohort study, 462 patients with locally advanced gastric cancer demonstrated a significantly improved survival after treatment ...
S-1 plus oxaliplatin noninferior to fluorouracil, leucovorin, and oxaliplatin in perioperative chemotherapy for locally advanced gastric cancer: FOCUS trial
1. This phase 3, randomized controlled trial demonstrated that S-1 plus oxaliplatin (SOX) was noninferior with respect to cancer-related outcomes ...
Direct comparison of neoadjuvant and adjuvant chemotherapy and radiotherapy for survival outcomes from resectable gastric cancer
1. Out of the therapies that were associated with longer overall survival versus no perioperative therapy, chemotherapy with unknown timing ...
Postoperative chemotherapy in chemosensitive patients undergoing surgical treatment of gastric cancer may prolong survival
1. Preoperative chemosensitivity was significantly associated with improved survival following receipt of surgery and adjuvant chemotherapy. 2. Amongst patients with ...
#VisualAbstract: Perioperative oxiplatin with S-1 significantly improves survival in patients with advanced gastric cancer or gastroesophageal adenocarcinoma undergoing D2 gastrectomy
Click to read the study in The Lancet Oncology.
Neoadjuvant apatinib therapy for locally advanced gastric cancer associated with high R0 resection rate
1. Neoadjuvant treatment of apatinib combined with S-1 plus oxaliplatin (SOX) was shown to be an effective treatment modality, resulting ...
Low and middle-income countries show greater post-operative mortality following cancer surgery
1. Low- and middle-income countries have a higher 30-day mortality in colorectal and gastric cancer surgeries compared with high-income countries. ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
